Search

everythinglearnresearchcommunity

for

Search:↓

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

A new genetic mutation in the TRPV3 gene causes Olmsted-like syndrome in a Mongolian family.

Localized ROS production is essential for cell growth and movement in plants and animals.

HLD10 can include increased body hair and Mongolian spots.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

Seven new genetic risk areas for prostate cancer were found.

Black wool in Qira sheep is linked to specific gene mutations, especially in the TYRP1 gene.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

PRX102 is essential for rice root hair growth by helping transport substances to the tips.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

The STIM1 R304W mutation in mice leads to bone changes and teeth hair growth.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

A new neural network helps identify key regulators in cell changes, aiding in understanding diseases and finding new treatments.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

CDP is crucial for lung and hair follicle cell development.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Olmsted syndrome can be inherited as an autosomal recessive trait due to a rare TRPV3 gene mutation.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.